Drugmaker Shire wins Baxalta for $32 billion after six-month pursuit

January 11, 2016 1:21 PM

20 0

Drugmaker Shire wins Baxalta for $32 billion after six-month pursuit

LONDON Drugmaker Shire Plc (SHP.L) clinched its six-month pursuit of Baxalta International Inc (BXLT.N) on Monday with an agreed $32 billion cash and stock offer, catapulting it to a leading position in treating rare diseases.

The London-listed group, which first approached the U.S. firm with an all-stock offer in July, won over the maker of treatments for rare blood conditions, cancers and immune system disorders after adding a cash sweetener.

Also read: Exxon Mobil Expands Permian Basin Footprint in Deal Worth More Than $5.6 Billion

Read more

To category page

Loading...